Skandinaviska Enskilda Banken AB A (0HBY)
London Exchange · UK · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 201.20 |
|---|---|
| 52-week range | 168.20 – 238.50 |
| Return, 1 month / 3 months | −13.4% / −6.6% |
| Return, 1 year / 3 years | +17.0% / +67.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 24 |
| Volatility (1 year) | 21.0% |
| Worst drawdown (1 year) | -14.8% |
| Average daily value traded | 88.85M SEK |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Skandinaviska Enskilda Banken, commonly known as SEB, is a Nordic bank based in Stockholm, Sweden. It provides banking and financial services to corporate and institutional clients as well as private individuals, including lending, savings and investment products, asset management, and life insurance. The bank operates across the Nordic region and in selected international markets, serving large companies, small and medium-sized businesses, and households through its branch network and digital channels.
The shares are listed on the London Exchange in UK under the code 0HBY, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Skandinaviska Enskilda Banken AB A (0HBY) trades on the London Exchange in UK. It last closed at SEK 201.20 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 276 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it fell 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.4% | ||
| From 52-week high | -14.8% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.6% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | 35.1% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.8% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 88.85M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −8.0% |
|---|---|
| 1 month | −13.4% |
| 3 months | −6.6% |
| 6 months | +11.0% |
| 1 year | +17.0% |
| 3 years | +67.5% |
| 5 years | +83.6% |
Signals
| 50-day / 200-day average | 224.98 / 198.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Mar 2026 | SEK 8.5000 |
| 2 Apr 2025 | SEK 3.0000 |
| 20 Mar 2024 | SEK 3.0000 |
| 5 Apr 2023 | SEK 6.7500 |
| 23 Mar 2022 | SEK 6.0000 |
| 15 Nov 2021 | SEK 4.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.